ICP DAS-BMP Marks Milestone in Medical-Grade TPU Materials with Agreement Signing Ceremony
On October 28, 2025, ICP DAS-BMP participated in a significant signing ceremony, organized by Towards Buddha Co., which marked a new milestone in the field of medical-grade Thermoplastic Polyurethane (TPU) materials. This event highlighted ICP DAS-BMP's substantial achievements in research and development, as well as the various applications these materials hold within the medical sector.
The ceremony gathered prominent partners from the industry, such as Intype Enterprise Co. Ltd, A-Max Technology Co. Ltd, MedServ Biotech Co. Ltd, LEON Biotech Co. Ltd, VOLER Biotech Consulting Co. Ltd, Chi Feng Co. Ltd, and Towards Buddha Co. Ltd. The combined expertise of these companies spans a broad spectrum, including TPU material manufacturing for medical purposes, smart manufacturing, Industrial Internet of Things (IIoT) applications, precision extrusion machinery, and regulatory consulting within medical device development.
ICP DAS-BMP specializes in a comprehensive range of medical-grade TPU materials tailored for diverse applications within the medical field, such as catheters, wire coatings, Luer-Lock connectors, and orthodontic components. The core TPU materials offered, including Arothane™, Alithane™, and Durathane™, meet the necessary criteria for most medical devices that are in body contact. Standout products like Arothane™ ARP-B20 and Durathane™ ALC-B40 have successfully passed the ISO 10993-6 implantation test for 13 weeks, qualifying them for implantation periods of up to 90 days. Their excellent dispersibility and biocompatibility make these materials prime choices for manufacturing invasive catheters.
As ICP DAS-BMP moves forward, they plan to strengthen their relationships with both existing clients and partners of the strategic agreement. They are committed to supplying high-quality medical-grade TPU materials that ensure safety for end-users. The company's ultimate goal is to boost its competitive edge within the global medical supply chain, enabling partners to develop more comprehensive and reliable medical devices.
ICP DAS-BMP, as a leading manufacturer based in Taiwan, boasts ISO 13485 certification and operates specialized labs focused on quality management. Drawing on over thirty years of industrial automation expertise from its parent company ICP DAS, the firm has implemented smart factory practices to enhance product quality and streamline delivery timelines. Their dedication extends to providing responsive after-sales service and flexible solutions for small order quantities, ensuring customer satisfaction and fostering long-term partnerships.
For more information on their offerings, visit ICP DAS-BMP. The signing ceremony and the collaboration it signifies are key steps towards advancing the application and adoption of TPU materials in the medical field, aligning perfectly with contemporary health care needs and innovations. Picture from the event and company logos can be accessed here and here respectively.
The ceremony gathered prominent partners from the industry, such as Intype Enterprise Co. Ltd, A-Max Technology Co. Ltd, MedServ Biotech Co. Ltd, LEON Biotech Co. Ltd, VOLER Biotech Consulting Co. Ltd, Chi Feng Co. Ltd, and Towards Buddha Co. Ltd. The combined expertise of these companies spans a broad spectrum, including TPU material manufacturing for medical purposes, smart manufacturing, Industrial Internet of Things (IIoT) applications, precision extrusion machinery, and regulatory consulting within medical device development.
ICP DAS-BMP specializes in a comprehensive range of medical-grade TPU materials tailored for diverse applications within the medical field, such as catheters, wire coatings, Luer-Lock connectors, and orthodontic components. The core TPU materials offered, including Arothane™, Alithane™, and Durathane™, meet the necessary criteria for most medical devices that are in body contact. Standout products like Arothane™ ARP-B20 and Durathane™ ALC-B40 have successfully passed the ISO 10993-6 implantation test for 13 weeks, qualifying them for implantation periods of up to 90 days. Their excellent dispersibility and biocompatibility make these materials prime choices for manufacturing invasive catheters.
As ICP DAS-BMP moves forward, they plan to strengthen their relationships with both existing clients and partners of the strategic agreement. They are committed to supplying high-quality medical-grade TPU materials that ensure safety for end-users. The company's ultimate goal is to boost its competitive edge within the global medical supply chain, enabling partners to develop more comprehensive and reliable medical devices.
ICP DAS-BMP, as a leading manufacturer based in Taiwan, boasts ISO 13485 certification and operates specialized labs focused on quality management. Drawing on over thirty years of industrial automation expertise from its parent company ICP DAS, the firm has implemented smart factory practices to enhance product quality and streamline delivery timelines. Their dedication extends to providing responsive after-sales service and flexible solutions for small order quantities, ensuring customer satisfaction and fostering long-term partnerships.
For more information on their offerings, visit ICP DAS-BMP. The signing ceremony and the collaboration it signifies are key steps towards advancing the application and adoption of TPU materials in the medical field, aligning perfectly with contemporary health care needs and innovations. Picture from the event and company logos can be accessed here and here respectively.
Topics Other）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.